We have received text from H.R. 10150: Advancing Botanical Drug Development Act of 2026. This bill was received on 2026-08-27, and currently has 1 cosponsor.
Here is a short summary of the bill:
This bill would create a special 12-year market exclusivity period for certain FDA-approved botanical drugs that are approved through a new drug application submitted after the bill becomes law.
What that means
- If a botanical drug is approved under the FDA’s standard new drug approval process, then for 12 years the FDA could not let a generic or other follow-on application referencing that drug become effective.
- This does not change the safety or effectiveness standards for approval. Botanical drugs would still need to meet the FDA’s normal requirements.
- The bill defines a botanical drug as one that is treated as a botanical drug under the FD&C Act, as determined by the Secretary through regulation.
Purpose described in the bill
The bill says botanical drugs can be harder and more expensive to develop than conventional drugs because plant-based ingredients can vary and require extra work to ensure consistent quality, safety, and effectiveness. It states that existing patent and exclusivity protections may not be enough to attract investment in this area, and that giving longer exclusivity could encourage more research and development of botanical treatments.
Practical effect
For companies that develop approved botanical drugs, the bill would provide a longer period of protection from direct FDA- अनुमाधित competition. That could give those products more time on the market without generic or similar follow-on versions. For patients and health care providers, the main effect would be on when lower-cost competing versions of those products could potentially become available.
Relevant Companies
None found
Representative Lauren Boebert Bill Proposals
Here are some bills which have recently been proposed by Representative Lauren Boebert:
- H.R.10150: Advancing Botanical Drug Development Act of 2026
- H.R.9979: Freedom to Ship Act
- H.R.9897: Trump-Reagan Election Enforcement Act
- H.R.9184: Local Data for Better Conservation Act
- H.R.8921: Freedom from Taxes Act of 2026
- H.R.8537: TRUMP Ballroom Act
You can track bills proposed by Representative Lauren Boebert on Quiver Quantitative's politician page for Boebert.
2026 Colorado's 4th Congressional District Election
There has been approximately $19,250,736 of spending in Colorado's 4th congressional district elections over the last two years, per our estimates.
Approximately $648,197 of this has been from outside spending by PACs and Super PACs. Some of the groups who are spending money in this race include:
- DEFEAT THE EXTREME FUND ($456,049)
- COLORADO UNITED PAC ($160,000)
- DEMOCRACY WINS ($19,809)
- HOUSE FREEDOM FUND ($5,548)
- OUR DEMOCRACY PAC ($3,790)
The rating for this race is currently "Solid R".
You can track this election on our matchup page for the 2026 Colorado's 4th congressional district election.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
